Riskpilot← Back to searchSign inGet full accessNamriftakovda Flu Nosbocaj AB
ABDissolvedOrg 5561853747Legal activities · NACE 6910Est. 19731 employees
Revenue 2021
SEK 235K
-2% vs 2020
EBITDA margin
25.5%
+200% vs 2020
Equity ratio
15.3%
Financial strength
Net profit 2021
SEK 52K
+230% vs 2020
| Revenue | SEK 235K | -2% |
| EBITDA | SEK 60K | +200% |
| Net profit | SEK 52K | +230% |
| Total assets | SEK 1,1M | +18% |
| Equity | SEK 162K | +47% |
| Employees | 1 | — |
Legal name
Namriftakovda Flu Nosbocaj AB
Org number
5561853747
Legal form
Aktiebolag
NACE code
6910 · Legal activities
Founded
28 november 1973
Share capital
SEK 0
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Company purpose
Bolaget skall bedriva konsulterande verksamhet inom juridik samt idka därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 591 | 526 | 371 | 241 | 235 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 254 | 197 | 49 | −60 | 60 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 254 | 197 | 49 | −60 | 60 |
| Net financials | — | 1 | 3 | — | — |
| Profit before tax | 255 | 198 | 53 | −40 | 61 |
| Tax | −58 | −45 | −12 | −0 | −9 |
| Net profit | 197 | 153 | 41 | −40 | 52 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 809 | 954 | 1 069 | 893 | 1 057 |
| Equity | 357 | 410 | 250 | 110 | 162 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 432 | 524 | 799 | 782 | 895 |
| Total debt | 432 | 524 | 799 | 782 | 895 |
EBITDA margin
25.5%
This company
15.8%
Market median
+61% vs market
20172021
Equity ratio
15.3%
This company
38.2%
Market median
-60% vs market
20172021
Return on equity
32.1%
This company
18.4%
Market median
+74% vs market
20172021
Net profit margin
22.1%
This company
8.1%
Market median
+173% vs market
20172021
Asset turnover
0.22×
This company
1.12×
Market median
-80% vs market
20172021
Debt / equity
5.52×
This company
0.62×
Market median
-790% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
BV | Audit | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (6) | ||
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Namriftakovda Flu Nosbocaj AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bengt Valfrid Bergshem | Audit | 0 companies |
| Leif Gustav Andersson | Deputy Board Member | 0 companies |
| Anna Maria Josefina Turesson | Deputy Board Member | 0 companies |
| Inger Margareta Dahle | Deputy Board Member | 0 companies |
| Manfred Ulf Jacobson | Board of Directors | 0 companies |
| Bengt Junior Niklas Nygårds | Deputy Board Member | 0 companies |
| Ulrika Margareta Ahlholm | Board of Directors | 0 companies |